Typical antipsychotic

Results: 308



#Item
221Microsoft PowerPoint - 2. FDA-AHRQ Collaboration - Kornegay.ppt

Microsoft PowerPoint - 2. FDA-AHRQ Collaboration - Kornegay.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English
222Atypical Antipsychotic Drug Use in the U.S. Outpatient Pediatric Population

Atypical Antipsychotic Drug Use in the U.S. Outpatient Pediatric Population

Add to Reading List

Source URL: www.fda.gov

Language: English
223Update to the PAC: Atypical Antipsychotics in the Pediatric Population Judith U. Cope, MD, MPH Office of Pediatric Therapeutics OC, FDA

Update to the PAC: Atypical Antipsychotics in the Pediatric Population Judith U. Cope, MD, MPH Office of Pediatric Therapeutics OC, FDA

Add to Reading List

Source URL: www.fda.gov

Language: English
22419 Atypical Drug Use in Children Cover

19 Atypical Drug Use in Children Cover

Add to Reading List

Source URL: www.fda.gov

Language: English
225Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
226Atypical Antipsychotic Drugs Utilization Data in Children

Atypical Antipsychotic Drugs Utilization Data in Children

Add to Reading List

Source URL: www.fda.gov

Language: English
227Attachment to DAL June 19, 2014 Warm Weather Advisory - Steps to be Taken by Adult Care Facilities in Wam Weather

Attachment to DAL June 19, 2014 Warm Weather Advisory - Steps to be Taken by Adult Care Facilities in Wam Weather

Add to Reading List

Source URL: www.health.ny.gov

Language: English - Date: 2014-07-07 16:16:59
228Microsoft PowerPoint - open meeting - Atypical antipsychotics.ppt

Microsoft PowerPoint - open meeting - Atypical antipsychotics.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English
229HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVEGA® SUSTENNA® safely and effectively. See full prescribing information for INVEGA® SUSTENNA®. INVEGA® SUSTE

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVEGA® SUSTENNA® safely and effectively. See full prescribing information for INVEGA® SUSTENNA®. INVEGA® SUSTE

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-08-31 14:12:19
230Articles  Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Stefan Leucht, Caroline Corves, Dieter Arbter, Rolf R Engel, Chunbo Li, John M Davis

Articles Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Stefan Leucht, Caroline Corves, Dieter Arbter, Rolf R Engel, Chunbo Li, John M Davis

Add to Reading List

Source URL: mentalhealth.vermont.gov

Language: English - Date: 2011-05-08 22:57:47